PETS Stock Analysis: Buy, Sell, or Hold?
PETS - PetMed Express, Inc.
$3.07
-0.12 (-3.76%)
▼
5d:
-6.12%
30d:
-4.06%
90d:
+21.83%
HOLD
LOW Confidence
Last Updated: February 2, 2026
Earnings: Feb 09, 2026
5d
Get Alerted When PETS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called PETS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PETS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PETS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: PETS is currently trading at $3.07, which is considered oversold relative to its 30-day fair value range of $3.22 to $3.43. The stock's valuation (Forward PE: 307.0) is in line with its historical norms (334.2). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This pessimistic expectation contrasts with the company's recent 266.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PETS is in a uptrend. The price is currently testing key support at $3.14. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.75. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PETS is in a uptrend. The price is currently testing key support at $3.14. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.75. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.22 -
$3.43
Company Quality Score
65/100
(BUY)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
66.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BEARISH: Trading 10.4% above Wall St target ($2.75)
- CAUTION: Recommendation downgraded due to -6.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$3.22 -
$3.43
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.45
(14.6%)
Support & Resistance Levels
Support Level
$3.14
Resistance Level
$3.52
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
307.00
Wall Street Target
$2.75
(-10.4%)
Revenue Growth (YoY)
-23.6%
Earnings Growth (YoY)
266.7%
Profit Margin
-27.8%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
307.0 vs 334.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$2.98
(-3%)
2-Year Target
$2.90
(-6%)
3-Year Target
$2.82
(-8%)
3-Yr Target (if PE normalizes)
(PE: 307→334)
$3.07
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 307.0 to 334.2
Stabilization Target:
$3.34
(+8.9%)
PE Expansion Potential:
+8.9%
Last updated: February 03, 2026 1:26 AM ET
Data refreshes hourly during market hours. Next update: 2:26 AM
Data refreshes hourly during market hours. Next update: 2:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PETS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Silvercape Investments L…
BUY
101000 shares
2025-08-13
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
5 analysts |
$6 | 52 HOLD |
